QIAGEN launches new QIAseq FastSelect solutions to accelerate RNAseq

QIAGEN reports preliminary Q3 2019 results and announces measures to prioritize resource allocation

QIAGEN announces CEO leadership transition

QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation (3)

Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation

Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation (2)

QIAGEN launches enhanced GeneGlobe Design & Analysis Hub, combining curated knowledge, content-based assays and analyses for life science research

QIAGEN announces winners of 2019 Young Investigator Award competition

QIAGEN announces change in global sales structure